Revolution Medicines, Inc.
MX ˙ BMV ˙ US76155X1000
SecurityMX:RVMD / Revolution Medicines, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership301,393 shares
Latest Disclosed Value $ 27,942,144
Jpmorgan Chase & Co ownership in RVMD / Revolution Medicines, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 301,393 shares of Revolution Medicines, Inc. (MX:RVMD) valued at $27,942,144 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 421,627 shares of Revolution Medicines, Inc.. This represents a change in shares of -28.52% during the quarter.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (RVMD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:RVMD / Revolution Medicines, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 301,393 -120,234 -28.52 27,942 -16.79 0.0002
2026-05-13 2026-03-31 13F REVOLUTION MEDICINES COMMON 76155X100 0 -100.00 0
2026-02-11 2025-12-31 13F REVOLUTION MEDICINES COMMON 76155X100 421,627 -2,076,700 -83.12 33,583 -71.22 0.0021
2025-11-26 2025-09-30 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 2,498,327 -338,901 -11.94 116,672 11.77 0.0070
2025-11-07 2025-09-30 13F REVOLUTION MEDICINES COMMON 76155X100 2,498,327 -338,901 116,672 0.0070
2025-08-12 2025-06-30 13F REVOLUTION MEDICINES COMMON 76155X100 2,837,228 -865,681 -23.38 104,382 -20.28 0.0068
2025-05-12 2025-03-31 13F REVOLUTION MEDICINES COMMON 76155X100 3,702,909 -126,440 -3.30 130,935 -21.83 0.0096
2025-02-12 2024-12-31 13F REVOLUTION MEDICINES COMMON 76155X100 3,829,349 -308,571 -7.46 167,496 -10.74 0.0125
2024-12-26 2024-09-30 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 4,137,920 1,022,345 32.81 187,655 55.19 0.0143
2024-11-08 2024-09-30 13F REVOLUTION MEDICINES COMMON 76155X100 4,137,920 1,022,345 187,655 0.0143
2024-12-26 2024-06-30 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 3,115,575 -393,529 -11.21 120,915 6.91 0.0099
2024-08-12 2024-06-30 13F REVOLUTION MEDICINES COMMON 76155X100 3,115,575 -393,529 120,915 0.0099
2024-12-26 2024-03-31 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 3,509,104 -882,525 -20.10 113,098 -10.20 0.0096
2024-05-10 2024-03-31 13F REVOLUTION MEDICINES COMMON 76155X100 3,509,104 -882,525 113,098 0.0096
2024-12-26 2023-12-31 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 4,391,629 111,710 2.61 125,952 6.32 0.0121
2024-02-12 2023-12-31 13F REVOLUTION MEDICINES COMMON 76155X100 4,391,629 111,710 125,952 0.0121
2023-11-14 2023-09-30 13F REVOLUTION MEDICINES COMMON 76155X100 4,279,919 312,166 7.87 118,468 11.62 0.0131
2023-08-11 2023-06-30 13F REVOLUTION MEDICINES COMMON 76155X100 3,967,753 705,115 21.61 106,137 50.19 0.0115
2023-05-18 2023-03-31 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 3,262,638 666,584 25.68 70,669 115,750.82 0.0086
2023-05-11 2023-03-31 13F REVOLUTION MEDICINES COMMON 76155X100 3,152,373 556,319 70,669 0.0010
2023-02-13 2022-12-31 13F REVOLUTION MEDICINES COMMON 76155X100 2,596,054 804,606 44.91 62 -99.83 0.0082
2022-11-14 2022-09-30 13F REVOLUTION MEDICINES COMMON 76155X100 1,791,448 -61,404 -3.31 35,327 -2.17 0.0051
2022-08-11 2022-06-30 13F REVOLUTION MEDICINES COMMON 76155X100 1,852,852 512,237 38.21 36,112 5.59 0.0050
2022-05-11 2022-03-31 13F REVOLUTION MEDICINES COMMON 76155X100 1,340,615 58,914 4.60 34,200 6.01 0.0041
2022-02-11 2021-12-31 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 1,281,701 -36,943 -2.80 32,261 -11.07 0.0037
2022-02-10 2021-12-31 13F REVOLUTION MEDICINES COMMON 76155X100 1,281,701 -36,943 32,261 0.0037
2021-11-12 2021-09-30 13F REVOLUTION MEDICINES COMMON 76155X100 1,318,644 -66,891 -4.83 36,277 -17.51 0.0045
2021-08-12 2021-06-30 13F REVOLUTION MEDICINES COMMON 76155X100 1,385,535 149,364 12.08 43,977 -22.46 0.0052
2021-05-12 2021-03-31 13F REVOLUTION MEDICINES COMMON 76155X100 1,236,171 76,031 6.55 56,716 23.48 0.0076
2021-02-19 2020-12-31 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 1,160,140 49,137 4.42 45,930 21.70 0.0067
2021-02-11 2020-12-31 13F REVOLUTION MEDICINES COMMON 76155X100 1,160,140 49,137 45,930 1,135.8816
2020-11-12 2020-09-30 13F/A-1 REVOLUTION MEDICINES COMMON 76155X100 1,111,003 337,784 43.69 37,741 54.61 0.0063
2020-11-12 2020-09-30 13F REVOLUTION MEDICINES COMMON 76155X100 1,111,003 37,741
2020-08-11 2020-06-30 13F REVOLUTION MEDICINES COMMON 76155X100 773,219 260,088 50.69 24,410 117.13 0.0047
2020-05-12 2020-03-31 13F REVOLUTION MEDICINES COMMON 76155X100 513,131 513,131 11,242 0.0026
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A REVOLUTION MEDICINES OPTION Put 128,000 11,867 n/a n/a n/a
2025-05-12 2025-03-31 13F REVOLUTION MEDICINES OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F REVOLUTION MEDICINES OPTION Put 3,200 -94.40 140 -94.63 n/a n/a n/a
2024-12-26 2024-09-30 13F/A REVOLUTION MEDICINES OPTION Put 57,100 1,684.38 2,589 1,987.90 n/a n/a n/a
2024-11-08 2024-09-30 13F REVOLUTION MEDICINES OPTION Put 57,100 2,589 n/a n/a n/a
2024-12-26 2024-06-30 13F/A REVOLUTION MEDICINES OPTION Put 3,200 124 n/a n/a n/a
2024-08-12 2024-06-30 13F REVOLUTION MEDICINES OPTION Put 3,200 124 n/a n/a n/a
2024-12-26 2023-12-31 13F/A REVOLUTION MEDICINES OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-12 2023-12-31 13F REVOLUTION MEDICINES OPTION Put 0 0 n/a n/a n/a
2023-11-14 2023-09-30 13F REVOLUTION MEDICINES OPTION Put 135,000 3,737 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.